These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 16330915)
1. Clopidogrel in acute coronary heart disease. Din JN; Fox KA Am Heart Hosp J; 2005; 3(4):234-42. PubMed ID: 16330915 [TBL] [Abstract][Full Text] [Related]
2. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Silva MA; Donovan JL; Gandhi PJ; Volturo GA Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468 [TBL] [Abstract][Full Text] [Related]
4. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. Mehta SR; Yusuf S J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):79S-88S. PubMed ID: 12644345 [TBL] [Abstract][Full Text] [Related]
5. Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone. Konopka A; Spychalska J; Sitkiewicz D; Zdebska E; Pilichowska I; Piotrowski W; Stepińska J Am J Cardiovasc Drugs; 2007; 7(6):433-9. PubMed ID: 18076210 [TBL] [Abstract][Full Text] [Related]
6. New antiplatelet agents. White HD; French JK; Ellis CJ Aust N Z J Med; 1998 Aug; 28(4):558-64. PubMed ID: 9777140 [TBL] [Abstract][Full Text] [Related]
7. Clopidogrel use in coronary heart disease and percutaneous coronary intervention. Atiemo AD; Williams MS J Investig Med; 2008 Apr; 56(4):689-700. PubMed ID: 18382265 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet agents in cardiology: the choice of therapy. Steinhubl SR Ann Thorac Surg; 2000 Aug; 70(2 Suppl):S3-8. PubMed ID: 10966004 [TBL] [Abstract][Full Text] [Related]
10. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis. Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034 [TBL] [Abstract][Full Text] [Related]
11. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379 [TBL] [Abstract][Full Text] [Related]
12. Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Gurbel PA; Bliden KP; Zaman KA; Yoho JA; Hayes KM; Tantry US Circulation; 2005 Mar; 111(9):1153-9. PubMed ID: 15738352 [TBL] [Abstract][Full Text] [Related]
13. Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study. Dalby M; Montalescot G; Bal dit Sollier C; Vicaut E; Soulat T; Collet JP; Choussat R; Gallois V; Drobinski G; Drouet L; Thomas D J Am Coll Cardiol; 2004 Jan; 43(2):162-8. PubMed ID: 14736431 [TBL] [Abstract][Full Text] [Related]
14. Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI). Tran H; Mehta SR; Eikelboom JW Vasc Health Risk Manag; 2006; 2(4):379-87. PubMed ID: 17323592 [TBL] [Abstract][Full Text] [Related]